Medical Genomics News
-
ExcellGene and Capricorn Scientific Forge Strategic Partnership to Revolutionize Biopharmaceutical Production
ExcellGene, a renowned Swiss biologics CDMO specializing in complex protein manufacturing services, using standard CHO and HEK293 expression systems and Capricorn Scientific, a leading German manufacturer of high-quality cell culture products, have joined forces in a strategic partnership to elevate the field of biopharmaceutical ...
-
Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services
Creative Proteomics, a leading provider of advanced proteomics services globally, has recently extended its services portfolio with protein post-translational modification (PTM) analysis. This new addition will provide valuable insights into the dynamic aspect of proteins, their regulation, and the fine-tuning of their functions. Proteins, while being the workhorse of cellular function, undergo ...
-
CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward
CD Genomics, a prominent leader in the next generation sequencing arena, proudly announce the launch of a groundbreaking 5mC/5hmC sequencing service. This innovative service is poised to empower researchers by providing a deeper insight into epigenetic variations, unlocking the mysteries of epigenetics, and catalyzing pivotal advancements in the realm of life science research and precision ...
By CD Genomics
-
CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service
CD Genomics, a global leader in genomics solutions, proudly announces the unveiling of its cutting-edge Full-Length 16S/18S/ITS Amplicon Sequencing service, designed to meet the comprehensive sequencing requirements of researchers in the fields of microbiology and mycology. This pioneering service represents a significant leap forward in genomics and offers an array of features aimed at ...
By CD Genomics
-
Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service
Creative Proteomics, the globally recognized proteomics, metabolomics, and multi-omics service provider, is delighted to introduce its exosome untargeted metabolomics services—a premier-stage offering in their broad catalogue services. Exosomes are tiny extracellular vesicles, hosting a diverse array of molecules including proteins, RNAs, and metabolites. With a diameter ranging between ...
-
Creative Proteomics Uplifts Protein Research with Cutting-Edge Molecular Mass Determination Services
Creative Proteomics, a leading global provider of advanced proteomics and metabolomics services, is excited to unveil its innovative Molecular Mass Determination service for proteins and peptides. As the understanding and utilization of peptides and proteins in the scientific field grow, the ability to accurately determine molecular mass and distribution becomes increasingly essential. In ...
-
Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing
Creative Enzymes, a leading global supplier and manufacturer of quality enzymes, is thrilled to introduce the availability of Recombinant Homocysteine Methyltransferase, dedicated to assisting researchers and industrial clients to unravel the complexity of enzyme activity. Originated from Pichia pastoris, the Homocysteine Methyltransferase, Recombinant has raised the bar in the field of ...
-
Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant
Creative Enzymes, a global leader in enzyme production, is thrilled to announce the latest addition to their hydrolase product line, the Recombinant S-Adenosyl-L-Homocysteine Hydrolase (SAHH). This announcement underscores its unwavering commitment to enzyme innovation and proven track to offering scientifically advanced products. SAHH, a crucial enzyme involved in the biological methylation ...
-
Creative Proteomics Introduces Methionine Cycle Analysis Service for Metabolomics Research
Creative Proteomics, a leading provider of advanced proteomics and metabolomics services, is proud to announce the launch of its innovative Methionine Cycle Analysis Service. This service represents a significant leap forward in the field of metabolomics, providing researchers with a powerful tool to unravel the complexities of metabolic pathways. Methionine, a pivotal amino acid, is central to ...
-
Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. This path-breaking move sees the integration of cutting-edge technology with state-of-art research facilities to amplify the possibilities of devising effective remedies for rare diseases. Rare ...
By Protheragen
-
Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
Creative Enzymes, a pioneering force in the field of biotechnology, has once again raised the bar in molecular biology with the launch of its Creative SuperCut Series. This breakthrough product line is designed to revolutionize the way scientists approach restriction enzyme digests, making it faster and more efficient than ever before. Creative Enzymes’ Creative SuperCut Series is ...
-
CD Genomics Unveils Cutting-Edge CRISPR Screen Sequencing Technology
CD Genomics, a distinguished leader in genomics and sequencing services, has proudly unveiled its groundbreaking CRISPR Screen Sequencing technology. This innovative solution promises to expedite discoveries, facilitate target identification, and optimize drug development pipelines within the biotechnology and pharmaceutical industries. CRISPR Screen Sequencing, a genome-wide screening ...
By CD Genomics
-
CD Genomics Revolutionizes TCR-Seq Elevating Immune Repertoire Profiling to New Heights
CD Genomics, an excellent leader in genomics and bioinformatics, has unveiled a groundbreaking leap forward in TCR-Seq technology, poised to revolutionize immune repertoire profiling. With an unwavering commitment to innovation and precision, CD Genomics continues to redefine the genomics research landscape. TCR-Seq, short for T Cell Receptor Sequencing, is an instrumental tool that enables ...
By CD Genomics
-
CD Genomics Introduces Cutting-Edge Degradome Sequencing Service Redefining Transcriptomics Research
CD Genomics, a prominent leader in the genomics and transcriptomics arena, proudly unveils its latest innovation, the Degradome Sequencing service. This technology promises to revolutionize the field of transcriptomics research, offering researchers an unprecedented window into RNA degradation patterns and elevating our comprehension of gene regulation and expression. RNA degradation is a ...
By CD Genomics
-
Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. The biological reagents previously launched by Alfa ...
-
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS (“bYoRNA”) today announced that they entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will help exploit the therapeutic potential of messenger RNA (“mRNA”). Dyadic is a global biotechnology company focused on building innovative ...
-
Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service
Creative Proteomics, a trailblazer in the realm of proteomics and genomics services, is proud to introduce its groundbreaking RNA Pull Down Service, poised to revolutionize the study of RNA-protein interactions. This transformative service transcends the boundaries of traditional methodologies, empowering researchers to unlock the enigma of cellular mechanisms and disease pathways. RNA-protein ...
-
CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems
CD Formulation, a reputable contract research organization (CRO) based in New York, has become a trusted partner for many pharmaceutical companies around the world seeking innovative drug formulation methods and solutions. Recently, CD Formulation further strengthened its role as a drug delivery expert by demonstrating its expertise in the development of cutting-edge CAR-T and CAR-NK cells for ...
-
Advances in Newborn SMA Screening research by SNP Biotechnology
BSD Robotics is proud to share a recent study conducted by SNP Biotechnology R&D Ltd “A new line method; A direct test in spinal muscular atrophy screening for DBS” now published in the journal of Molecular Genetics and Genomic Medicine. Given spinal muscular atrophy (SMA) is one of the most prevalent genetic disorders affecting young children and a major cause of death in ...
By BSD Robotics
-
CD Genomics Launches Mature HLA Typing Solutions Enabling Precision Immune Profiling
CD Genomics, a renowned leader in genomics and next-generation sequencing (NGS) applications, has unveiled its cutting-edge HLA typing solutions, revolutionizing immune profiling and transplantation compatibility assessment. The human leukocyte antigen (HLA) system plays a crucial role in immune regulation and determining transplantation compatibility. HLA typing, the process of identifying ...
By CD Genomics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you